Crown BioScience experts explore organoid models and high-content imaging to evaluate T-cell-targeted therapies and ...

A team of researchers has successfully created more effective immune cells that can fight cancer without damaging healthy ...

Even in the case of uncomplicated infections, the body prepares itself early on for the possibility of a more severe course.

image: QRICH1 fine-tunes the signaling of T cell receptors by regulating CARD11 view more Credit: Nicole M. Carter In a study ...

The research groups led by Wolfgang Kastenmüller and Georg Gasteiger employed innovative microscopy techniques to observe how ...

A bold funding initiative aims to help scientists predict a T cell’s target antigens, with implications far beyond cancer therapy.

T cells are white blood cells that are important for adaptive immunity. They have unique cell surface receptors that are generated by randomly assorting genes. These receptors allow T cells to ...

Chimeric antigen receptor t-cell, or CAR-T therapy, uses a person’s own immune cells to attack cancer. Dean Berhaupt is the first person in the Capital Region to receive the therapy as he battles ...

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science of addressing critical issues with CAR T cell therapy in patients with ...

CAR T-cell therapy has significantly improved outcomes for B-ALL patients, but relapse still occurs in over 50% of cases, leaving many with limited treatment options. Ongoing research aims to ...

Even in the case of uncomplicated infections, the body prepares itself early on for the possibility of a more severe course. A research team has now uncovered this mechanism. The scientists showed ...